Silexion Therapeutics announces exercise of warrants for $3.3M gross proceeds
Source: SeekingAlpha
2025-01-29 17:48:15 ET
- Silexion Therapeutics ( NASDAQ: SLXN ) announced the entry into definitive agreements for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 2.22M of shares originally issued in January 2025 having an exercise price of $1.35/share.
- The gross proceeds from the exercise of the warrants are expected to be ~$3.3M.
- The offering is expected to close on or about January 30, 2025.
- SLXN intends to use the net proceeds from the offering as working capital for general corporate purposes.
- SLXN shares down 34% post-market on Wednesday.
- Source: Press release
Read the full article on Seeking Alpha
For further details see:
Silexion Therapeutics announces exercise of warrants for $3.3M gross proceeds
Silexion Therapeutics Corp
NASDAQ: SLXN
SLXN Trading
1202.95% G/L:
$5.26 Last:
181,356 Volume:
$4.29 Open:
SLXN Latest News
May 20, 2026 01:20:00 pm
Biotech Stock Silexion Therapeutics Corp. (NASDAQ: SLXN) Soars on Update and First Quarter Results
May 20, 2026 11:49:53 am
Biotech and Biologics Break Out: These Tiny Stocks Are Suddenly Dominating the Market Conversation
May 18, 2026 08:30:00 am
Silexion Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
SLXN Stock Data
$5,158,959
2,939,043
62.46%
9
N/A
Biotechnology & Life Sciences
Healthcare
US
Ramat-Gan
